CAS number：1593673-23-4 molecular formula：C27H36N2O4
Etripamil (MSP-2017) is a short-acting L-type calcium-channel antagonist, can be used for the research of Paroxysmal Supraventricular Tachycardia (PSVT). Etripamil (MSP-2017) slows atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells Form:Oil IC50& Target:L-type calcium channel
| Chinese alias | 乙曲帕米 | ||
| English alias | D10932 | S82A18Y42P | MS)-MSP-2017 | Q27289030 | methyl 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-methylamino]ethyl]benzoate | Etripamil | Etripamil [INN] | methyl (S)-3-(2-((4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)(methyl)amino)eth | ||
| CAS number | 1593673-23-4 | molecular formula | C27H36N2O4 |
| molecular weight | 452.59 g/mol | Exact mass | ≥98% |
| PSA | 71.800 Ų | logp | 3.7 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
